Preview: Anavex Life Sciences's Earnings
Portfolio Pulse from Benzinga Insights
Anavex Life Sciences (NASDAQ:AVXL) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.17. The company's past performance shows a pattern of beating EPS estimates, which has sometimes led to an increase in share price. However, the stock has been down 27.82% over the last 52-week period.
August 07, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Anavex Life Sciences is expected to report an EPS of $-0.17 in its upcoming earnings report. The company has a history of beating EPS estimates, which could potentially lead to a short-term increase in share price. However, the stock has been down 27.82% over the last year, indicating a bearish sentiment among long-term shareholders.
The company's history of beating EPS estimates could lead to a short-term increase in share price if the trend continues. However, the overall bearish trend over the last year indicates that long-term investors may not be optimistic about the company's performance. The upcoming earnings report could potentially influence the stock's direction, but it's uncertain at this point.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100